trading halt, page-55

One would've thought they had pre-drafted the announcement since it will be at max a two pager and more detailed results would be released publicly to academia etc.

Scenario a: Positive outcome regarding safety and tolerability. Inconclusive/negative outcome regarding efficacy. The company will continue blah blah but really, we're doomed.

Scenario b: Slam dunk baby. 'Nuff said.

Scenario c: x people died in the trial or lost a limb. I think we can safely discount this scenario since they would have had to stop the trial in this case.

I guess in order to look after their interests in the US they might wait until tomorrow. Then again if the news were positive it wouldn't matter. Up is up. Argh. Let's just hope they don't release anything during US trading hours on Tuesday night. They just might given where the major volume sits.